Abstract |
Vigabatrin, as a single oral dose of 50 mg/kg, was administered to 11 patients with drug-refractory complex partial epilepsy. Serial lumbar punctures were performed prior to and 5 times within the first week following treatment. Cerebrospinal fluid (CSF) concentrations of total GABA, free GABA, homocarnosine, homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and vigabatrin were determined as well as blood vigabatrin levels. CSF GABA, homocarnosine, HVA and 5-HIAA concentrations increased by 6 h after the single dose and remained elevated for up to 5-7 days. In contrast, CSF and blood vigabatrin levels were maximal within the first 24 h and were no longer detectable thereafter. Hence, these results are consistent with vigabatrin acting as an irreversible inhibitor of GABA-transaminase and suggest that it may also increase biogenic amine turnover.
|
Authors | E B Menachem, L I Persson, P J Schechter, K D Haegele, N Huebert, J Hardenberg, L Dahlgren, J P Mumford |
Journal | Epilepsy research
(Epilepsy Res)
1988 Mar-Apr
Vol. 2
Issue 2
Pg. 96-101
ISSN: 0920-1211 [Print] Netherlands |
PMID | 3143561
(Publication Type: Journal Article)
|
Chemical References |
- Aminocaproates
- Dipeptides
- Serotonin
- homocarnosine
- gamma-Aminobutyric Acid
- Carnosine
- Vigabatrin
- Homovanillic Acid
|
Topics |
- Administration, Oral
- Adult
- Aminocaproates
(administration & dosage, cerebrospinal fluid, therapeutic use)
- Carnosine
(analogs & derivatives, cerebrospinal fluid)
- Dipeptides
(cerebrospinal fluid)
- Epilepsies, Partial
(cerebrospinal fluid, drug therapy)
- Female
- Homovanillic Acid
(cerebrospinal fluid)
- Humans
- Male
- Middle Aged
- Serotonin
(cerebrospinal fluid)
- Vigabatrin
- gamma-Aminobutyric Acid
(cerebrospinal fluid)
|